Effect of corticosteroids on human osteoclast formation and activity

Area of Science:

• Endocrinology
• Cell Biology
• Bone Biology

Background:

• Chronic corticosteroid use is a significant cause of bone loss and osteoporosis.
• Osteoclasts, derived from monocyte precursors, are key cells responsible for bone resorption.
• Understanding the direct effects of glucocorticoids on osteoclasts is crucial for managing corticosteroid-induced bone loss.

Purpose of the Study:

• To investigate the impact of the synthetic glucocorticoid, dexamethasone, on human osteoclast formation.
• To assess the effect of dexamethasone on the bone-resorbing activity of osteoclasts.
• To elucidate the direct mechanisms by which dexamethasone influences osteoclastogenesis and function.

Main Methods:

• Human monocytes were cultured with RANKL and M-CSF in the presence or absence of dexamethasone.
• Osteoclast formation and differentiation were assessed by counting tartrate-resistant acid phosphatase-positive multinucleated cells.
• Bone-resorbing activity was quantified by measuring lacunar resorption on dentine slices and resorption pit formation in isolated osteoclasts.

Main Results:

• Dexamethasone significantly increased the formation of multinucleated osteoclasts and enhanced lacunar resorption when added during early culture periods (7-14 days).
• Conversely, dexamethasone reduced lacunar resorption when added after osteoclast activity had commenced (after 14 days).
• Dexamethasone significantly inhibited resorption pit formation in isolated mature osteoclasts.

Conclusions:

• Dexamethasone directly stimulates the proliferation and differentiation of human osteoclast precursors.
• Dexamethasone inhibits the bone-resorbing activity of mature osteoclasts.
• These dual effects of dexamethasone on osteoclasts may contribute to the complex bone remodeling observed during chronic corticosteroid treatment.